|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2007-12-20
|
|
pubmed:abstractText |
The role of NKG2D receptor in antitumor immunosurveillance has not been completely clarified. We addressed this issue by investigating the involvement of this receptor in tumor-specific immunologic response in melanoma patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7459-68
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:18094430-Cell Line, Tumor,
pubmed-meshheading:18094430-Clone Cells,
pubmed-meshheading:18094430-Flow Cytometry,
pubmed-meshheading:18094430-Humans,
pubmed-meshheading:18094430-Immunohistochemistry,
pubmed-meshheading:18094430-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:18094430-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:18094430-Melanoma,
pubmed-meshheading:18094430-NK Cell Lectin-Like Receptor Subfamily K,
pubmed-meshheading:18094430-Receptors, Immunologic,
pubmed-meshheading:18094430-Receptors, Natural Killer Cell,
pubmed-meshheading:18094430-T-Lymphocyte Subsets,
pubmed-meshheading:18094430-T-Lymphocytes,
pubmed-meshheading:18094430-Tumor Escape
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
|
|
pubmed:affiliation |
Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori, Milan, Italy. maccalli.cristina@hsr.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
